Radiolabelled Nectin-4 Targeted LMW Probe PET/CT in Patients With Lung Lesions
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorPeking University Cancer Hospital & Institute
About this trial
To evaluate the ability of \[68Ga\]N188 to detect nectin-4 overexpression in patients with lung lesions.
Eligibility criteria
Qualifiers
18-75 years old, male or female;
Heart function is normal;
Normal heart function;
Estimated survival ≥12 weeks;
Disqualifiers
Serious abnormality of liver, kidney and blood;
Pregnant patients;
Pregnant and lactation women;
Trial design
Treatments tested in this trial
- FDG-PET
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov